Diagnostic Potential of S. mansoni Egg and Worm Antigens for Urogenital Schistosomiasis in Resource-Limited Settings

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Sulaiman K.A.; Oriade T.O.; Auta T.; Afolayan F.I.D.; Odaibo A.B.; Grenfell R.F.Q.; Fatem R.G.; Oyeyemi O.T.

Journal: Parasite Immunology

Publisher: John Wiley and Sons Inc

Publication Date: 16 July 2025

Volume / Issue: Volume 47 / Issue 7

Article No.: e70015

ISSN: 1419838

DOI: 10.1111/pim.70015

Scopus: View on Scopus

PubMed: 40671165

Document Type: Article


Authors and Affiliations

Sulaiman K.A., Department of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Nigeria, Tropical Medicine & Diagnostics Development Group, Seeding Graduate Laboratory, University of Medical Science, Ondo, Nigeria; Oriade T.O., Department of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Nigeria, Tropical Medicine & Diagnostics Development Group, Seeding Graduate Laboratory, University of Medical Science, Ondo, Nigeria; Auta T., Department of Biological Sciences, Federal University Dutsin-Ma, Katsina, Nigeria; Afolayan F.I.D., Department of Zoology, University of Ibadan, Oyo, Ibadan, Nigeria; Odaibo A.B., Department of Zoology, University of Ibadan, Oyo, Ibadan, Nigeria; Grenfell R.F.Q., Diagnosis and Therapy of Infectious Diseases and Cancer, Rene Rachou Institute, Oswaldo Cruz Foundation (Fiocruz), Minas Gerais, Belo Horizonte, Brazil, Department of Infectious Diseases, University of Georgia, Athens, GA, United States; Fatem R.G., Schistosome Biological Supply Center, Theodor Bilharz Research Institute, Giza, Egypt; Oyeyemi O.T., Department of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Nigeria, Tropical Medicine & Diagnostics Development Group, Seeding Graduate Laboratory, University of Medical Science, Ondo, Nigeria


Abstract

Around 90% of those at risk for schistosomiasis live in Africa, with urogenital schistosomiasis (UGS) prevalent in Sub-Saharan Africa. This study examines Schistosoma mansoni egg and worm antigens as cost-effective diagnostic alternatives, addressing challenges in maintaining S. haematobium in animal models. Sera and urine samples from schistosomiasis endemic and non-endemic areas were analysed against S. mansoni worm (Sm SWA) and egg antigens (Sm SEA) using indirect ELISA to detect S. haematobium specific antibodies. Microscopy was adopted as the diagnostic reference standard. Sensitivity (SS) ranged from 80% to 96%, and specificity (SP) ranged from 42% to 90%. Sm SWA showed slightly higher sensitivity than Sm SEA in negative non-endemic (NNE) populations. The best area under the curve (AUC) was 0.96 for Sm SEA-NNE. Both antigens performed better in diagnosing UGS in non-endemic samples, suggesting their suitability among travellers arriving from endemic areas. The anti-schistosomal IgG responses to Sm SWA and SEA in both negative endemic (NE) and NNE samples were statistically significant (p < 0.0001) compared to positive samples, except in NE sera samples tested with Sm SEA. Key findings indicate that Sm SEA and SWAP are effective diagnostic tools for S. haematobium infection, with high sensitivity suggesting their potential for new immunodiagnostic methods for UGS. © 2025 John Wiley & Sons Ltd.


Keywords

immunodiagnostic tools; indirect ELISA; Schistosoma mansoni antigens; sensitivity and specificity; urogenital schistosomiasis (UGS); Adolescent; Adult; Africa South of the Sahara; Animals; Antibodies, Helminth; Antigens, Helminth; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Male; Resource-Limited Settings; Schistosoma haematobium; Schistosoma mansoni; Schistosomiasis haematobia; Schistosomiasis mansoni; Young Adult; antibody; antigen; cross reacting antibody; helminth antibody; parasite antigen; Article; ascariasis; Ascaris lumbricoides; asymptomatic infection; blood sampling; child; cohort analysis; controlled study; cost effectiveness analysis; diagnostic test accuracy study; human; human tissue; major clinical study; microscopy; nonhuman; parasite serodiagnosis; resource limited setting; schistosomiasis; Strongyloides stercoralis; strongyloidiasis; Taenia saginata; travel; urine sampling; urogenital tract infection; animal; blood; diagnosis; enzyme linked immunosorbent assay; evaluation study; immunology; procedures


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

Transcriptome analysis for Schistosoma vector snail’s Oncomelania hupensis exposed to silver nanoparticles

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer